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Transcatheter aortic valve replacement (TAVR) has been used as an alternative to surgical 
aortic valve replacement in severe aortic stenosis patients with successful mid-term 
outcomes.1)2) Hypoattenuated leaflet thickening (usually indicating leaflet thrombosis) 
and reduced leaflet motion have been reported in association with both transcatheter and 
surgical aortic bioprosthetic valves.3) Using multidetector by computed tomography (CT), 
subclinical leaflet thickening is documented more frequently than expected, as transthoracic 
echocardiography is considered being unsuitable for the detection.3)4) A recent meta-analysis 
reported that subclinical leaflet thrombosis is seen on CT in 11.5% of patients after TAVR and 
is associated with increased risk of stroke.5) However, whether anticoagulation can reduce 
these phenomena after TAVR is not established, because data on this topic from randomized 
trials are lacking.
Besides hypoattenuated leaflet thickening, other findings such as subvalvular thickening 
and thrombosis of Sinus of Valsalva are not uncommonly encountered on post-TAVR CT.6) 
Although alterations of hemodynamics in sinuses of Valsalva can affect the development 
of thrombosis, sinus of Valsalva thrombosis after TAVR has been scarcely reported. In this 
issue of Korean Circulation Journal, Lim et al.7) reported the clinical and cardiac CT findings 
of patients with sinus of Valsalva thrombosis after TAVR. On a retrospective review of 
192 patients underwent cardiac CT after TAVR, 9 patients (4.7%) had sinus of Valsalva 
thrombosis on cardiac CT, 3 of which had concomitant leaflet thrombosis. Sinus of Valsalva 
thrombosis was frequently detected in the non-coronary sinus, and predominantly located 
in the bottom of the sinus extending upward towards the sinotubular junction. Three of 9 
patients with sinus of Valsalva thrombosis had subclinical embolic stroke on brain magnetic 
resonance imaging. The authors suggested that Sinus of Valsalva thrombosis after TAVR 
should be regarded as a potential target of anticoagulation treatment to prevent systemic 
embolization or coronary obstruction.
The findings of the study are interesting, but clinical implication is limited because of the 
selection bias and lack of relationship between sinus of Valsalva thrombosis and clinical 
consequence. First, the study population consisted of patients who underwent post-TAVR 
CT with various clinical indications and heterogeneous time interval from TAVR, and only 




Received: May 1, 2020
Accepted: May 20, 2020
Correspondence to
Young Joo Suh, MD, PhD
Department of Radiology, Severance Hospital, 
Yonsei University College of Medicine, 50-1, 
Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
E-mail: rongzusuh@gmail.com
Copyright © 2020. The Korean Society of 
Cardiology
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted noncommercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
Young Joo Suh 
https://orcid.org/0000-0002-2078-5832
Conflict of Interest
The author has no financial conflicts of 
interest.
The contents of the report are the author's 
own views and do not necessarily reflect the 
views of the Korean Circulation Journal.
Young Joo Suh , MD, PhD
Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Post-Procedural Computed 
Tomography after Transcatheter 
Aortic Valve Replacement: New 
Insights into Patient Management
► See the article “Sinus of Valsalva Thrombosis Detected on Computed Tomography after Transcatheter 
Aortic Valve Replacement” in volume 50 on page 572.
28.9% of the entire patients who underwent TAVR was included in the study. Moreover, brain 
magnetic resonance imaging to investigate embolic stroke was performed in only one-third 
of the study population. Second, the association between sinus of Valsalva thrombosis and 
embolic stroke after TAVR was unclear because only borderline statistical significance was 
demonstrated on the univariate logistic regression analysis.
To date, clinical implication of sinus of Valsalva thrombosis detected on post-TAVR CT is 
not sufficient to provide new insight to post-TAVR follow-up, despite this finding is novel 
and unexpected. However, the importance of post-procedural CT imaging should not be 
overlooked, as we noted in the case of leaflet thrombosis. There is an increasing awareness of 
bioprosthetic aortic valve thrombosis after TAVR owing to the usage of post-procedural CT 
in clinical trials,8) which can have potential to change post-procedural patient management 
such as anticoagulation. Another issue regarding the leaflet thickening in bioprosthetic aortic 
valve is its potential relationship with early structural valve degeneration.9)10) Recently, long-
term durability of transcatheter aortic valve has received attention as TAVR is increasingly 
being used for younger, lower-risk patients. A recent study suggested a time-dependent 
degeneration of transcatheter valves consisting of thrombosis formation, endothelial 
hyperplasia, fibrosis, tissue remodeling, proteinase expression, and calcification.10) Until 
now, the mechanism contributing leaflet thrombosis and structural valve degeneration and 
impact on the post-procedural anticoagulation should be further investigated. Although 
optimal follow-up interval of post-procedural CT is not established, future investigation 
using post-procedural CT imaging as an endpoint is warranted to further understand 
mechanisms of post-procedural findings and their clinical implications.
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